Deep Brain and Cortical Stimulation
Customize your policy alerts
Sign up for sierra health and life Policy 2026T0321KK alerts
Get alerted when Policy 2026T0321KK changes without checking for updates manually.
Monitor payer policy activity
Clinical coverage policy for use of deep brain stimulation (DBS) and responsive cortical stimulation (RNS) for neurologic indications under UnitedHealthcare Commercial and Individual Exchange plans; affects providers seeking prior authorization and reimbursement for neurostimulation procedures.
Created shared policy version to support application to Oxford plan membership and archived previous policy version 2025T0321JJ and SURGERY 090.32.
Coverage Criteria for Neurostimulation
Medically Necessary Indications
Covered when indications are met and InterQual criteria applied:
Refer to InterQual CP for medical necessity clinical coverage criteria for procedures and stereotactic electrode implantation.
Refer to InterQual CP for details.
Unproven / Not Medically Necessary Indications
Not medically necessary / unproven uses due to insufficient evidence of efficacy:
Multiple systematic reviews and small RCTs exist but are considered insufficient to generalize efficacy and safety.
Coverage considerations for DBS in treatment‑resistant OCD
Coverage considerations reflect evidence that DBS may benefit a subset of patients with severe, treatment‑resistant OCD but is limited by study quality and should be performed in specialized centers; see criteria logic below.
Supported by guideline and systematic review statements
Per NICE and evidence summaries
See systematic reviews and guideline uncertainty
Responsive Cortical Stimulation
Responsive cortical stimulation — coverage stance
Policy states insufficient evidence for non‑epilepsy indications
Deep brain stimulation (DBS) and cortical stimulation for obsessive-compulsive disorder (OCD) and for indications not specifically listed as medically necessary are considered unproven and not medically necessary due to insufficient evidence of efficacy. The policy therefore excludes DBS and cortical stimulation for OCD and all other nonlisted indications from standard coverage outside of specified, evidence‑based indications.
Responsive cortical stimulation (RNS) for indications other than partial or focal seizure disorders lacks sufficient clinical evidence and is therefore considered experimental/investigational and not medically necessary for non‑seizure indications such as OCD until larger, well‑designed studies establish safety and efficacy.
Reiterating the policy stance: Deep brain stimulation and cortical stimulation for OCD and all other indications not explicitly listed as covered are not medically necessary because current evidence is inadequate to demonstrate consistent efficacy and safety for these uses.
Clinical guidance from NICE notes that evidence on the safety and efficacy of DBS for chronic, severe, treatment‑resistant OCD in adults is inadequate in quality and quantity and therefore recommends that DBS for this indication be used only in the context of research. NICE also specifies that patient selection should be by a multidisciplinary team and procedures performed in centers with DBS expertise, and calls for further randomized controlled trials with defined targets and outcome measures. Separately, responsive cortical stimulation is similarly limited by insufficient evidence for non‑seizure indications and requires larger, well‑designed studies to establish safety and long‑term outcomes.
Applicable Procedure and Product Codes
| 61850 | Twist drill or burr hole(s) for implantation of neurostimulator electrodes, cortical. |
| 61860 | Craniectomy or craniotomy for implantation of neurostimulator electrodes, cerebral, cortical. |
| 61863 | Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; first array. |
| 61864 | Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; each additional array (List separately in addition to primary procedure). |
| 61867 | Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; first array. |
| 61868 | Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; each additional array (List separately in addition to primary procedure). |
| 61885 | Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive |
| 61886 | Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to 2 or more electrode arrays. |
| 61889 | Insertion of skull-mounted cranial neurostimulator pulse generator or receiver, including craniectomy or craniotomy, when performed, with direct or inductive coupling, with connection to depth and/or cortical strip electrode array(s). |
| 61891 | Revision or replacement of skull-mounted cranial neurostimulator pulse generator or receiver with connection to depth and/or cortical strip electrode array(s). |
| 64999 | Unlisted procedure, nervous system. |
| L8679 | Implantable neurostimulator, pulse generator, any type. |
| L8680 | Implantable neurostimulator electrode, each. |
| L8682 | Implantable neurostimulator radiofrequency receiver. |
| L8685 | Implantable neurostimulator pulse generator, single array, rechargeable, includes extension. |
| L8686 | Implantable neurostimulator pulse generator, single array, nonrechargeable, includes extension. |
| L8687 | Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension. |
| MHY, NHL, OLM, OLX | FDA product codes referenced for deep brain stimulation devices |
| PFN | FDA product code referenced for responsive cortical devices |
Provider Requirements and Prior Authorization
Prior authorization required; use InterQual criteria and listed codes
Coverage of deep brain and responsive cortical stimulation is subject to medical necessity review and prior authorization; submit requests referencing the InterQual® CP: Procedures, Stereotactic Introduction, Subcortical or Cortical Electrodes and include the applicable procedure and device codes when requesting review.
- Use listed CPT/HCPCS and HCPCS L‑codes (see coding section) on the prior authorization request.
- Reference InterQual clinical coverage criteria for implantation and procedure medical necessity determination.
Verify multidisciplinary selection and center expertise during prior auth
Prior authorization must verify that patient selection and the planned procedural setting meet multidisciplinary team and center expertise expectations described by guidelines (psychiatry, neuropsychiatry, clinical psychology, neurology, neurosurgery and DBS experience) before approval.
- Include documentation that patient selection was made by a multidisciplinary team experienced in managing the relevant disorder and DBS.
- Document that the procedure will be performed at a center with DBS expertise and experience managing the specific condition.
DBS for OCD is considered last‑line per guideline literature
Document that DBS is being considered only after standard treatments have failed; literature and guideline reviews generally recommend DBS as a last‑line therapy for OCD.
- Include prior treatment history showing failure of other evidence‑based therapies before DBS is pursued.
Document stepwise prior therapies and consideration of alternative surgeries
Prior authorization and medical record review require documentation of prior standard therapies and consideration of alternative surgical options; include rationale for choosing DBS over ablative surgery and evidence of medically refractory disease.
- Provide records of prior pharmacologic, psychotherapeutic, and neuromodulatory treatments and their outcomes.
- Document discussions of surgical alternatives (e.g., lesioning) including risks, patient preference, and clinician experience.
Provide medical records and use listed procedure/device codes
Medical records and the procedure/diagnosis codes listed in the coding section may be required to assess whether the member meets clinical criteria; include operative notes, diagnostic assessments, and relevant CPT/HCPCS/L‑codes on submissions.
- Attach operative reports, pre‑ and post‑operative assessments, and specialist consultation notes.
- List applicable procedure and device codes on authorization and claims; inclusion of a code does not guarantee coverage or payment.
Document multidisciplinary evaluation and center expertise
Documentation should reflect multidisciplinary evaluation and center experience — include notes from psychiatry, neuropsychiatry or clinical psychology, neurology, and neurosurgery documenting consensus on candidacy and management plan.
- Include signed consultation notes from each relevant specialty documenting assessment, rationale, and treatment recommendations.
- Document center-level DBS experience and team composition.
Documentation may affect but does not guarantee coverage
Medical records submitted to support a request may be necessary to determine whether coverage criteria are met, but providing documentation does not guarantee approval; coverage remains subject to the member’s specific benefit plan and applicable laws.
- Ensure documentation aligns with InterQual criteria and member specific benefit plan terms.
- Recognize that documentation aids review but does not itself establish coverage.
NICE research‑only recommendation for DBS in OCD may affect coverage
NICE guidance states DBS for chronic, severe, treatment‑resistant OCD should only be used in the context of research due to inadequate evidence quality and quantity; absence of evidence that the proposed treatment meets research or center criteria may lead to denial.
- If DBS is proposed outside a research context, include justification that addresses NICE concerns or evidence of research framework/oversight if applicable.
- Document center-level participation in research or protocols when available.
Background and Evidence Summary
Deep brain stimulation (DBS) involves surgically implanted electrodes placed in specific subcortical targets (examples include the internal globus pallidus, subthalamic nucleus, and ventral intermediate nucleus) connected to an implantable pulse generator that delivers continuous electrical pulses to modulate abnormal neural circuits. The system components include intracranial electrode leads, extensions, and an implantable pulse generator; stimulation is adjustable and reversible compared with lesional procedures. Responsive cortical stimulation (RNS) systems are closed‑loop devices that detect abnormal electrical activity and deliver stimulation in response, typically using intracranial leads and a skull‑mounted neurostimulator to prevent seizure development.
Terms and Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.